Abstract
Lithium is the primary choice for preventing bipolar disorder relapses, endorsed by guidelines. A recent systematic review by Ulrichsen et al. showed limitations in assessing its specific impact, but data supports lithium's effectiveness in managing symptoms and preventing relapse. Comprehensive guidelines and research are crucial for its continued use.
Original language | English |
---|---|
Article number | e187 |
Journal | BJPsych open |
Volume | 9 |
Issue number | 6 |
Number of pages | 2 |
ISSN | 2056-4724 |
DOIs | |
Publication status | Published - Nov 2023 |
Keywords
- Bipolar type 1 or 2 disorders
- complimentary therapies
- depressive disorders
- mood stabilisers
- statistical methodology